These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4719852)

  • 1. Parkinson's disease and physical therapy management.
    Wroe M; Greer M
    Phys Ther; 1973 Aug; 53(8):849-55. PubMed ID: 4719852
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's syndrome--modern therapy, known facts and unanswered questions.
    Albert E
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Sep; 6(5):229-46. PubMed ID: 4604872
    [No Abstract]   [Full Text] [Related]  

  • 3. The modifying influence of L-dopa on the physical therapy program in Parkinson's disease.
    Blonsky ER; Minnigh EC
    Prog Phys Ther; 1970; 1(1):55-74. PubMed ID: 5523796
    [No Abstract]   [Full Text] [Related]  

  • 4. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of treatment with levodopa and rehabilitative therapy in 10 cases of Parkinson's disease].
    Paciaroni E; Raspa EG
    Sist Nerv; 1970; 22(2):153-61. PubMed ID: 5504554
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parkinson disease].
    Lauschke HP; Thieme F
    Z Arztl Fortbild (Jena); 1981 Aug; 75(15):681-5. PubMed ID: 6125059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systematization of the treatment of the patient with parkinsonism after the introduction of dihydrophenylalanine].
    Carneiro W
    Rev Bras Med; 1972 Mar; 29(3):124-5. PubMed ID: 5033150
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Parkinson's syndrome].
    Fortschr Med; 1982 Jun; 100(24):1172. PubMed ID: 7106681
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract]   [Full Text] [Related]  

  • 10. Levodopa and physical therapy in treatment of patients with Parkinson's disease.
    Stern PH; McDowell F; Miller JM; Robinson M
    Arch Phys Med Rehabil; 1970 May; 51(5):273-7. PubMed ID: 5420013
    [No Abstract]   [Full Text] [Related]  

  • 11. A double blind study of 1-dopa treatment in Parkinson's disease.
    Rinne UK; Sonninen V
    Eur Neurol; 1968; 1(3):180-91. PubMed ID: 4880674
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of L-dopa in Parkinson's disease].
    Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parkinson's syndrome. 2. Nuclei and extrapyramidal tracts].
    Andén NE
    Lakartidningen; 1970 Oct; 67(42):4807-12 passim. PubMed ID: 5478704
    [No Abstract]   [Full Text] [Related]  

  • 14. Interrelations between the extrapyramidal and autonomic structures, functions and dysfunctions revealed by a study of Parkinson's disease.
    Ferrari E; Simone F
    Acta Neurol (Napoli); 1986 Oct; 8(5):501-15. PubMed ID: 3799255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Parkinson's syndrome. 5. Pathophysiologic mechanisms].
    Steg G
    Lakartidningen; 1970 Oct; 67(42):4821-3. PubMed ID: 5478707
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical and clinical correlations in Parkinson's disease].
    Barbeau A
    Rev Neurol (Paris); 1972 Aug; 127(2):253-64. PubMed ID: 4603361
    [No Abstract]   [Full Text] [Related]  

  • 17. EEG and urinary non-catecholic amine changes during L-dopa therapy of Parkinson's disease.
    Marjerrison G; Boulton AA; Rajput AH
    Dis Nerv Syst; 1972 Mar; 33(3):164-9. PubMed ID: 5022451
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of response to levodopa in Parkinson's disease.
    Mones RJ
    JAMA; 1971 Aug; 217(9):1245. PubMed ID: 5109470
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmaco-biochemical mechanisms and modern therapy in Parkinsonian syndromes].
    Bartholini G; Tissot R
    Rev Med Liege; 1970 Sep; 25(18):591-607. PubMed ID: 5511964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.